Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review paper

Explore by Goal

Quick Answer Copied

This is a competent narrative review consolidating the ncRNA–ferroptosis–CRC axis, cataloging ~30 ncRNAs that modulate ferroptosis and their prognostic potential, but it generates no new data and acknowledges its own translational gaps (small samples, unclear mechanisms).

Long Answer

The review by Zhao et al. synthesizes how ncRNAs (miRNAs, lncRNAs, circRNAs) regulate ferroptosis in colorectal cancer, largely via the SLC7A11–GPX4 axis, influencing tumor growth, metastasis, and chemoresistance .

Strengths

The paper provides a comprehensive, well-organized catalog of ~30 ncRNA–ferroptosis interactions in CRC, with a clear mechanistic figure. It honestly identifies translational barriers: small sample sizes, unclear mechanisms, and the dominance of the SLC7A11-GPX4 axis over other ferroptosis defenses.

Critical Gaps

The review does not mention ferritinophagy (NCOA4-mediated ferritin degradation), a validated ferroptosis driver relevant to iron overload and relevant to CRC metabolism . It also omits mTORC1-mediated GPX4 regulation, a key axis for chemo-resistance . Broader ferroptosis-disease associations (95 curated by FerrDb) suggest the field extends well beyond CRC .

This visualization uses only directional information from the paper's Table 1; vertical jitter is for label separation and does not represent a continuous variable.

Feedback:

Updated: October 24, 2026

BGPT Paper Review

Study Novelty

50%

Consolidates prior mechanistic findings on ncRNA–ferroptosis in CRC; no novel conceptual framework or data.

Scientific Quality

60%

Narrative review without systematic search; citations are generally sound but many primary studies are small-sample bioinformatic models; the authors honestly flag their own translational barriers.

Study Generality

60%

Findings are CRC-specific and largely mechanistic; the ncRNA–ferroptosis axis concept has broader relevance but is not generalized here.

Study Usefulness

70%

Useful roadmap for investigators and clinicians interested in ferroptosis-associated biomarkers; but clinical application remains distant.

Study Reproducibility

50%

No new data generated; reproducibility of the cited primary studies is generally poor due to small cohorts and lack of independent validation.

Explanatory Depth

70%

Mechanistic detail is solid for SLC7A11-GPX4-axis-focused findings but incomplete regarding ferroptosis defense axes (e.g., ferritinophagy, FSP1) relevant to CRC.

🎁 Authors: Collect 88 Free Science Tokens (≈ $8.8 USD)

Claim My Author Tokens

Use for 22 days of free BGPT access (4 tokens = 1 day) or trade/sell (≈ $8.8 USD)

Top Data Sources Export MCP

1. Role of non-coding RNA-regulated ferroptosis in colorectal cancer [2025]

7QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

2. Autophagy promotes ferroptosis by degrading ferritin via ferritinophagy, with NCOA4 acting as the selective cargo receptor; genetic inhibition of Atg5/Atg7 reduces erastin-induced ferroptosis and ferritin degradation, while altering NCOA4 levels modulates ferroptosis through ferritin turnover. [2016]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

3. A comprehensive progress report surveying ferroptosis biology and ferroptosis inducers for cancer therapy, detailing underlying mechanisms (iron metabolism, ROS, lipid peroxidation, GPX4/SLC7A11), in vitro and in vivo models, nanomaterial-based strategies, and the challenges and future directions for translating ferroptosis induction into clinical cancer treatment. [2019]

9QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

4. The study shows that castration induces ferroptosis as the primary mechanism of distal luminal cell death in the prostate, regulated by dual AR pathways—intrinsic NKX3.1-dependent signaling and extrinsic stromal PTN–AKT/mTORC1 signaling—whose coordinated inactivation triggers ferroptosis in mice and is supported by human tissue data, suggesting ferroptosis induction as a therapeutic angle for prostate cancer. [2025]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

5. The study identifies talaroconvolutin A (TalaA) as a novel natural ferroptosis inducer that kills colorectal cancer cells in vitro and suppresses tumor growth in vivo by elevating ROS and modulating ferroptosis-related genes (downregulating SLC7A11 and upregulating ALOXE3 and HMOX1), outperforming erastin and implicating a dual ROS/ferroptosis mechanism with in vivo efficacy and low observed toxicity. [2020]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

Key Insight

Most ncRNA–ferroptosis regulation in CRC funnels through a single defense axis (SLC7A11–GPX4), suggesting a fragile chokepoint that could be exploited or that alternative defense systems remain underexplored.

Keep Exploring

Which non-SLC7A11 ferroptosis defense axes (FSP1, DHODH, MBOAT1/2) are regulated by ncRNAs in CRC cell lines, and do they confer resistance that SLC7A11 targeting cannot overcome?

Does pharmacologic suppression of mTORC1, which promotes GPX4 synthesis, synergize with ncRNA-targeted ferroptosis induction in preclinical CRC models?

Hypothesis Graveyard

Ferroptosis is irrelevant to CRC therapy because CRC cells are uniquely resistant—falsified by the review's own cited examples of oxaliplatin and cetuximab resistance reversal via ferroptosis induction.

All ncRNAs in CRC act through ceRNA sponging—falsified by multiple direct protein-interaction mechanisms (e.g., LINC00239 binding KEAP1) reported in the review.

Potential Experiments

CRISPR screen in CRC organoids targeting all ferroptosis-related lncRNAs to quantify causal effect sizes on GPX4 activity, replacing correlative small-cohort models.

Patient-derived xenograft test of combining a system xc− inhibitor with SLC7A11-antisense to overcome 5-FU resistance in a personalized CRC model.

Science Art

Paper Review: Role of non-coding RNA-regulated ferroptosis in colorectal cancer Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data is skewed toward SLC7A11-GPX4-dominant ferroptosis narratives, which may bias me toward overemphasizing that axis despite the broader FerrDb landscape.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

My BGPT

Trending